Salência-Ferrão Judite, Chissaque Assucênio, Manhique-Coutinho Lena, Kenga Andrea Ntanga, Cassocera Marta, de Deus Nilsa
Instituto Nacional de Saúde, Marracuene district, EN1, Bairro da Vila- Parcela nr 3943, Maputo, Mozambique.
Hospital Central de Maputo, Avenida Agostinho Neto n° 164, Maputo, Mozambique.
BMC Infect Dis. 2025 Feb 12;25(1):209. doi: 10.1186/s12879-025-10597-z.
Even with a great reduction in the last years, diarrhoea continues to be one of the leading causes of hospital admission and mortality in children less than five years of age globally. The success of diarrhoeal disease management relies on the rapid recognition of the symptoms and adequate treatment, with World Health Organization (WHO) guidelines, limiting the use of antibiotics for all diarrhoea cases being reserved to specific circumstances. Therefore, this study aimed to evaluate the frequency of antibiotics use in diarrhoea management in children aged 0-59 months admitted with acute diarrhoea in four provinces of Mozambique, from 2014 to 2019.
A cross-sectional hospital-based surveillance was conducted from January 2014 to December 2019 in six sentinel sites located in four provinces. Socio-demographic, epidemiological and clinical data were obtained by interviewing the child's caregivers and by accessing the child's medical records and children's vaccination card. Data collected through National Surveillance of Diarrhoea (ViNaDia) was double-entered in Epi Info3.5.1. (Centers for Disease Control and Prevention, Atlanta 2008), followed by data comparison. IBM SPSS software was used to conduct the data analysis.
During the study period 2014-2019 a total of 2382 children presenting at one of the designated health facilities were enrolled via ViNaDia surveillance. Of these 85.1% (2028/2382) provided data of antibiotics (ATB) usage and thus included in the present analysis. The majority was male with 59.3% (1203/2028), with infants aged 0-11 months composing the largest age group with 49.4% (1002/2028). Nutritional assessment revealed that 28.8% (585/2028) were underweight and 15.2% (308/2028) faced wasting. The comorbidities included human immunodeficiency virus (HIV) 7.8% (159/2028), malaria 7.0% (141/2028), and pneumonia 2.1% (42/2028). The rates of bloody diarrhoea and "rice-water" were reported in 1.5% (10/1664) and 2% (29/1664) respectively. Antibiotics use was reported in 93.2% of the children [95% CI: 92.0-94.2; 1890/2028], with s 49.1% [95% CI: 47.0-51.5; 930/1890] received more than one ATB. The most prescribed antibiotics were Ampicillin (46.2%), Gentamicin (38.4%) and Cotrimoxazole (30.5%).
The results of this study indicate inappropriate use of antibiotics in the management of acute diarrhoea in children attended in four provinces of Mozambique. The study suggests the drawing of a local guideline for the efficient management of acute diarrhoea, and the need for education on adherence of WHO recommendations on antibiotics use in acute diarrhoea.
尽管在过去几年中腹泻率大幅下降,但腹泻仍是全球五岁以下儿童住院和死亡的主要原因之一。腹泻病管理的成功依赖于对症状的快速识别和适当治疗,世界卫生组织(WHO)的指南规定,仅在特定情况下才对所有腹泻病例使用抗生素。因此,本研究旨在评估2014年至2019年期间莫桑比克四个省份0至59个月急性腹泻住院儿童在腹泻治疗中使用抗生素的频率。
2014年1月至2019年12月,在四个省份的六个哨点开展了一项基于医院的横断面监测。通过采访儿童看护者并查阅儿童病历和儿童预防接种证获取社会人口统计学、流行病学和临床数据。通过国家腹泻监测(ViNaDia)收集的数据在Epi Info3.5.1(美国疾病控制与预防中心,亚特兰大,2008)中进行双录入,随后进行数据比对。使用IBM SPSS软件进行数据分析。
在2014 - 2019年研究期间,通过ViNaDia监测共纳入了2382名到指定医疗机构就诊的儿童。其中85.1%(2028/2382)提供了抗生素使用数据,因此纳入本分析。大多数为男性,占59.3%(1203/2028),0至11个月的婴儿构成最大年龄组,占49.4%(1002/2028)。营养评估显示,28.8%(585/2028)体重不足,15.2%(308/2028)面临消瘦。合并症包括人类免疫缺陷病毒(HIV)感染7.8%(159/2028)、疟疾7.0%(141/2028)和肺炎2.1%(42/2028)。血性腹泻和“米汤样”腹泻的发生率分别为1.5%(10/1664)和2%(29/1664)。93.2%的儿童使用了抗生素[95%置信区间:92.0 - 94.2;1890/2028],其中49.1%[95%置信区间:47.0 - 51.5;930/1890]接受了不止一种抗生素治疗。最常开具的抗生素是氨苄西林(46.2%)、庆大霉素(38.4%)和复方新诺明(30.5%)。
本研究结果表明,莫桑比克四个省份就诊的儿童在急性腹泻治疗中存在抗生素使用不当的情况。该研究建议制定当地急性腹泻有效管理指南,并需要开展关于遵守WHO急性腹泻抗生素使用建议的教育。